GlassScriptPhysician profile
Jean Paul Gray
NPI 1801881438
$1,596.96
in general payments reported to CMS, 2019-2025
27 companies · $419 in 2025
The $419 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $101 · 2021: $146 · 2022: $209 · 2023: $147 · 2024: $384 · 2025: $419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $950.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $218.16 | 2019-2025 | Veozah |
| Amgen INC. | $153.49 | 2019-2024 | Evenity, Prolia |
| Daiichi Sankyo INC. | $118.62 | 2020-2025 | Injectafer |
| Takeda Pharmaceuticals U.S.A., INC. | $118.37 | 2019-2025 | Trintellix |
| Exeltis, USA INC. | $117.93 | 2023-2025 | Slynd |
| Glaxosmithkline, LLC. | $105.58 | 2021-2025 | Shingrix, Bexsero |
| Mayne Pharma Commercial LLC | $101.72 | 2022-2025 | |
| Abbvie INC. | $91.86 | 2021-2024 | |
| Biogen, INC. | $78.43 | 2024 | Zurzuvae |
| Coopersurgical, INC. | $66.96 | 2023-2024 | Fisherbrand Disposable Liquid Infant Heel Warmer, Advincula Delineator Uterine Manipulator |
| Hologic Sales and Service, LLC | $56.67 | 2025 | Aptima, Myosure Tissue Removal Device, Novasure |
| Organon LLC | $43.81 | 2024-2025 | Nexplanon |
| Pfizer INC. | $40.69 | 2022-2024 | |
| Pacira Pharmaceuticals Incorporated | $37.01 | 2023-2024 | Exparel, Iovera |
| Sumitomo Pharma America, INC. | $34.26 | 2025 | Myfembree |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $28.07 | 2022 | |
| Amag Pharmaceuticals, INC. | $23.46 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.81 | 2023 | |
| Medtronic, INC. | $20.56 | 2022 | |
| Exact Sciences Corporation | $18.50 | 2024 | Cologuard Collection Kit |
| Agile Therapeutics, INC. | $18.41 | 2021 | |
| Urovant Sciences INC | $18.18 | 2022 | |
| Avion Pharmaceuticals | $13.99 | 2019 | |
| Millicent US INC | $13.53 | 2025 | Intrarosa, Femring |
| Merck Sharp & Dohme LLC | $13.07 | 2022 | |
| Minerva Surgical, INC | $12.02 | 2021 | |
| Evofem Biosciences, INC. | $11.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.